Literature DB >> 2797728

Pupillary fibrin membrane. A frequent early complication after posterior chamber lens implantation in Japan.

K Miyake1, K Maekubo, Y Miyake, O Nishi.   

Abstract

The incidence of pupillary fibrin membrane formation, a relatively frequent complication of cataract surgery in Japan even for experienced surgeons, was noted in 2038 consecutive cases of senile cataract removal and primary posterior chamber intraocular lens (PC IOL) implantation. The overall incidence was 4.4%. Comparisons among cases showed the incidence to be significantly higher among: (1) patients who received dry- versus wet-sterilized lenses (P less than 0.001), (2) eyes with premature, subcapsular, or nuclear cataracts than among those with mature cataracts (P less than 0.05), (3) patients with systemic hypertension (P less than 0.01), (4) eyes not treated postsurgically with topical antiprostaglandins (P less than 0.001), and (5) patients who had undergone previous PC IOL implantation in the fellow eye (P less than 0.001). These findings suggest that the formation of the fibrin membrane is a kind of immunologic reaction. Accordingly, use of antiprostaglandin agents and complete removal of lens material and epithelial cells are recommended, especially for patients undergoing second-eye operations or those with a predisposition to breakdown of the blood-aqueous barrier.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797728     DOI: 10.1016/s0161-6420(89)32746-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Pupillary membrane after cataract extraction with posterior chamber lens in glaucoma patients.

Authors:  A J Geerards; C T Langerhorst
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

2.  Glaucoma triple procedure comprising trabeculotomy with a fornix-based scleral flap.

Authors:  Y Saito; A Oo; S Okamoto; Y Kuwayama; H Nakatani
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

3.  Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts.

Authors:  O Nishi; K Nishi; M Imanishi
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

4.  To Study the Efficacy of Difluprednate Ophthalmic Emulsion and Prednisolone Acetate Ophthalmic Suspension on Post-operative Inflammation in Cataract Surgery.

Authors:  Punita Garg; Nupur Tuteja; Shazia Qayum
Journal:  J Clin Diagn Res       Date:  2016-12-01

5.  The role of difluprednate ophthalmic emulsion in clinical practice.

Authors:  Karim N Jamal; David G Callanan
Journal:  Clin Ophthalmol       Date:  2009-06-29

6.  Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery.

Authors:  Stephen Smith; Douglas Lorenz; James Peace; Kimberly McLeod; R S Crockett; Roger Vogel
Journal:  Clin Ophthalmol       Date:  2010-09-07

7.  Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report.

Authors:  Hideaki Yoshino; Masaaki Seki; Jun Ueda; Takaiko Yoshino; Takeo Fukuchi; Haruki Abe
Journal:  BMC Ophthalmol       Date:  2012-03-20       Impact factor: 2.209

8.  The Nd:YAG laser as first-line treatment for fibrin pupillary-block glaucoma following uncomplicated cataract surgery.

Authors:  Selina Khan; Mohamed Elashry
Journal:  Oxf Med Case Reports       Date:  2019-01-24

9.  Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery.

Authors:  Timothy-Paul H Kung; Charles Zhang; Sandra F Sieminski
Journal:  Am J Ophthalmol Case Rep       Date:  2022-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.